SYNERGY is Boston Scientific’s everolimus-eluting platinum-chromium stent with an ultra-thin (~4 µm) abluminal PLGA polymer that is absorbed together with the drug within about four months, leaving a bare PtCr stent. Strut thickness is 74 µm for this diameter. The platform carries a one-month DAPT indication in high-bleeding-risk patients (EVOLVE Short DAPT).
Reference H7493926220270: 2.75 mm × 20 mm, nominal pressure 11 atm, rated burst pressure 18 atm, 0.017″ tip profile, 5F guide compatible, 0.014″ guidewire, monorail delivery system 144 cm.
Available to order from Med Technologies — new, in original manufacturer packaging, CE-marked, with lot traceability. Contact us for pricing, stock and compatible sizes.







